ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call

Chandan Healthcare Earnings Call: Key Takeaways

Chandan Healthcare reported robust FY26 results with 20.43% revenue growth, transitioning to a pan-India diagnostic model while scaling franchise and PPP projects.

Why this was an Alfa AlertNot a filter event. Results are strong but did not exceed a specific prior guided range by 10% or more.
Highlights
Revenue growth20.43% YoY for FY26.
MarginsEBITDA margin 20.25%; target 30-35% during expansion phase.
Order book₹800cr project value over 10 years for five PPP projects.
Demand visibilityStrong; fueled by PPP projects and expansion into 13 states.
Management confidenceHigh; citing aggressive expansion and maturing of existing centers.

Growth

FY26 Revenue: ₹280.67cr (+20.43% YoY); EBITDA: ₹56.84cr (+31.02% YoY); PAT: ₹27.06cr (+22.04% YoY).

Outlook

Targeting 1,000 franchises in 24 months; adding 5 comprehensive centers and 20 labs in FY27.

Risks

One-time ₹2.92cr impact from new Labor Code; long receivable cycles in government/B2G segments.

Source

Earnings Call filed with NSE, NSE: CHANDAN. Summary written with AI assistance from the document.

Read the document ↗

Chandan Healthcare Ltd: key numbers

Share price
₹238.00
Market cap
₹611.7 Cr
Revenue (annual)
₹276.4 Cr
Net profit (annual)
₹27.06 Cr
P/E (TTM)
22.6×Sector 54.5×
Promoter holding
47.20%-2.41% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Chandan Healthcare Ltd

All →